Literature DB >> 31169634

Sacubitril/valsartan improves medium-term reverse left ventricular remodeling: why wait?

Gloria Santangelo1, Francesca Bursi1, Filippo Toriello1, Federica Valli1, Elisabetta Tombolini2, Daniela Torta1, Laura Bosotti1, Laura Massironi1, Stefano Carugo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31169634     DOI: 10.2459/JCM.0000000000000825

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


× No keyword cloud information.
  1 in total

1.  Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort Study.

Authors:  Renato De Vecchis; Andrea Paccone; Marco Di Maio
Journal:  Cardiol Res       Date:  2019-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.